Home/Pipeline/Dupixent

Dupixent

Atopic dermatitis

CommercialMarketed

Key Facts

Indication
Atopic dermatitis
Phase
Commercial
Status
Marketed
Companies

About Sanofi

Sanofi is one of the world's largest pharmaceutical companies, leveraging artificial intelligence and deep immunology expertise to develop breakthrough treatments and vaccines. With a comprehensive pipeline spanning multiple therapeutic areas and a strong commercial portfolio of established medicines, the company is committed to improving global health outcomes. Their recent focus on AI-powered drug discovery and development positions them at the forefront of pharmaceutical innovation.

View full company profile

About Regeneron Pharmaceuticals

Regeneron Pharmaceuticals is a premier biotechnology company founded in 1988 and headquartered in Tarrytown, New York. The company has built a diversified portfolio of FDA-approved treatments and maintains a robust pipeline across oncology, immunology, ophthalmology, and other therapeutic areas. Regeneron's proprietary VelociSuite technologies, including VelocImmune mice and advanced manufacturing capabilities, enable rapid drug discovery and development. With multiple billion-dollar commercial products and strong financial performance, Regeneron ranks among the most successful biotech companies globally.

View full company profile

About Regeneron Pharmaceuticals

Regeneron Pharmaceuticals is a premier biotechnology company founded in 1988 and headquartered in Tarrytown, New York. The company has built a diversified portfolio of FDA-approved treatments and maintains a robust pipeline across oncology, immunology, ophthalmology, and other therapeutic areas. Regeneron's proprietary VelociSuite technologies, including VelocImmune mice and advanced manufacturing capabilities, enable rapid drug discovery and development. With multiple billion-dollar commercial products and strong financial performance, Regeneron ranks among the most successful biotech companies globally.

View full company profile

Other Atopic dermatitis Drugs

DrugCompanyPhase
LebrikizumabEli LillyPhase 3
ASP2408Astellas PharmaPhase 2
KW-6356Kyowa KirinPhase 2
KHK4083Kyowa KirinPhase 2
Opzelura (ruxolitinib cream)Ono PharmaceuticalApproved
ONO-7913Ono PharmaceuticalPhase 2
KT-474Kymera TherapeuticsPhase 2
GRC 27864Glenmark PharmaceuticalsPhase 2
ARQ-234Arcutis BiotherapeuticsPreclinical/Phase 1
STAR-0310BioCryst PharmaceuticalsPhase 1
RezpegaldesleukinNektar TherapeuticsPhase 2b
ZL-1503Zai LabPhase (Early Clinical)